KPMA calls for more rational approach to new drug pricing policy

The so-called positive list system reinforces the government's rash approach to shaping policies, according to the Korea Pharmaceutical Manufacturers Association (KPMA).

The KPMA said the ministry will have to overcome many problems to guarantee the success of the new drug pricing system.

The highlight of the reform package is to enable the national health insurance to pay for medicines t...